PB Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2002) 26: 455-457. doi: 10.1192/pb.26.12.455
© 2002 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, A.
Right arrow Articles by Boddy, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scott, A.
Right arrow Articles by Boddy, H.
Psychiatric Bulletin (2002) 26: 455-457
© 2002 The Royal College of Psychiatrists

Induction agents in electroconvulsive therapy: a comparison of methohexitone and propofol

Allan Scott, Consultant Psychiatrist and Honorary Senior Lecturer, c/o Research/Administration Assistant

Special Committee on ECT, The Royal College of Psychiatrists, Scottish Division, 9 Queen St, Edinburgh EH2 1JQ, UK

Harold Boddy, Senior House Officer in Psychiatry

Andrew Duncan Clinic, Royal Edinburgh Hospital, Morningside Terrace, Edinburgh EH10 5HF

Declaration of interest

None.

AIMS AND METHOD

To compare methohexitone and propofol in electroconvulsive therapy (ECT). A retrospective within-subject comparison was made of the use of these drugs in separate courses of bilateral ECT in one clinic over 10 years. Patients taking mood stabilising or anti-epileptic drugs were excluded. The initial seizure threshold and seizure duration were of particular interest.

RESULTS

The median initial seizure thresholds were identical (75 mC). The median initial seizure duration with threshold stimulation was 25% shorter with propofol (21 v. 28 s). The median total numbers of treatments in the courses were identical (eight treatments).

CLINICAL IMPLICATIONS

The shorter seizure duration observed with propofol was not associated with a commensurate rise in the initial seizure threshold. The shorter seizure duration may therefore have no effect on the therapeutic efficacy of treatment.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2002 The Royal College of Psychiatrists.